Cancer Biomarkers Funding Opportunities

Titlesort descending Announcement # Expiration Date
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems PAR-20-155 (R01 Clinical Trial Optional) 09/08/2022
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research RFA-CA-21-006 (R33 Clinical Trial Not Allowed) 09/30/2021
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-21-004 (R33 Clinical Trial Not Allowed) 09/29/2021
Advanced Development of Informatics Technologies for Cancer Research and Management RFA-CA-21-015 (U24 Clinical Trial Optional) 11/18/2021
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-20-314 (UH3 Clinical Trials Not Allowed) 10/11/2023
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) PAR-20-313 10/11/2023
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention PAR-19-251 (R01 Clinical Trial Optional) 11/09/2021
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention PAR-19-252 (R21 Clinical Trial Optional) 11/09/2021
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research PAR-19-113 (R01 Clinical Trial Optional) 01/08/2022
Co-infection and Cancer PAR-20-062 (R01 Clinical Trial Not Allowed) 01/08/2023
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management RFA-CA-21-013 (R21 Clinical Trial Optional) 11/18/2021
Early-Stage Development of Informatics Technologies for Cancer Research and Management RFA-CA-21-014 (U01 Clinical Trial Optional) 11/18/2021
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer PAR-19-264 (R01 Clinical Trial Optional) 12/11/2021
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research RFA-CA-21-005 (R21 Clinical Trial Not Allowed) 09/30/2021
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-21-003 (R21 Clinical Trial Not Allowed) 09/30/2021
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) PAR-20-088 04/02/2022
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed) PAR-20-081 04/02/2022
Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection NOT-CA-20-067 (R01 Clinical Trial Not Allowed) 01/08/2023
Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD) NOT-CA-20-031 01/08/2022
Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers NOT-CA-21-028 01/08/2024
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions NOT-CA-20-044 05/08/2023
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit PAR-21-335 (U24 Clinical Trial Not Allowed) 06/12/2024
Pancreatic Cancer Detection Consortium: Research Units PAR-21-334 (U01 Clinical Trial Optional) 06/12/2024
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection PAR-20-053 (R01 Clinical Trial Not Allowed) 01/08/2023
Revision Applications to Support the Application of Informatics Technology for Cancer Research RFA-CA-21-018 (U01 Clinical Trials Optional) 11/18/2021
Revision Applications to Support the Application of Informatics Technology for Cancer Research RFA-CA-21-019 (U24 Clinical Trial Optional) 11/19/2021
Revision Applications to Support the Application of Informatics Technology for Cancer Research RFA-CA-21-017 (R01 Clinical Trials Optional) 11/18/2021
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PAR-20-277 (R21 Clinical Trials Not Allowed) 09/08/2022
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PAR-20-276 (R01 Clinical Trial Not Allowed) 09/08/2022
Sustained Support for Informatics Technologies for Cancer Research and Management RFA-CA-21-016 (U24 Clinical Trial Optional) 11/18/2021
Translational and Basic Science Research in Early Lesions (TBEL) RFA-CA-21-054 (U54 Clinical Trial Not Allowed) 11/03/2021
Translational and Basic Science Research in Early Lesions (TBEL) Coordinating and Data Management Center RFA-CA-21-055 (U24 Clinical Trial Not Allowed) 11/03/2021